Inhibiting casein kinase 2 sensitizes acute lymphoblastic leukemia cells to venetoclax via MCL1 degradation

BLOOD ADVANCES

ELSEVIER

1. Deutsche Carreras LeukaEuromie Stiftung [DJCLS 01R/2016, DJCLS 10R/2017]
2. German Research Foundation (DFG) [SFB 1074]
3. Wilhelm Sander-Stiftung [2018.116.1]
4. Ulm University
5. Charite-Universita Eurotsmedizin Berlin
6. Berlin Institute of Health